Todd Asset Management LLC Gilead Sciences, Inc. Transaction History

Todd Asset Management LLC

$4.09 Billion
Q3 2024

A detailed history of Todd Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Todd Asset Management LLC holds 12,506 shares of GILD stock, worth $1.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

12,506

Previous 12,506 -0.0%

Holding current value

$1.16 Million

Previous $858,000 22.14%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $2,652 - $3,060	42 Added 0.34%	12,506 $858,000
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $31,566 - $38,494	441 Added 3.67%	12,464 $912,000
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $20 Million - $22.7 Million	-273,340 Reduced 95.79%	12,023 $973,000
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $1.98 Million - $2.16 Million	26,720 Added 10.33%	285,363 $21.4 Million
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $18.5 Million - $21.2 Million	243,993 Added 1665.48%	258,643 $19.9 Million
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $7,499 - $8,543	97 Added 0.67%	14,650 $1.22 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $105,258 - $151,114	-1,689 Reduced 10.4%	14,553 $1.25 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $15,480 - $17,682	260 Added 1.63%	16,242 $1 Million
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $19,278 - $21,713	334 Added 2.13%	15,982 $988,000
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $13,900 - $17,419	240 Added 1.56%	15,648 $930,000
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $147,361 - $158,986	-2,177 Reduced 12.38%	15,408 $1.08 Million
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $191,171 - $208,882	-3,012 Reduced 14.62%	17,585 $1.21 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $1.24 Million - $1.41 Million	20,597 New	20,597 $1.33 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $17.7 Million - $19.6 Million	-248,883 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $182,896 - $213,341	-2,819 Reduced 1.12%	248,883 $17.6 Million
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $1.23 Million - $1.5 Million	-16,913 Reduced 6.3%	251,702 $19 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $4.08 Million - $4.79 Million	57,341 Added 27.14%	268,615 $19.2 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $15.2 Million - $18.1 Million	211,274	211,274 $17.1 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.

Account

Todd Asset Management LLC Gilead Sciences, Inc. Transaction History